CORE 4 - FLOW CYTOMETRY CORE ? ABSTRACT The Joslin Flow Cytometry Core's primary objective is to provide state-of-the-art flow cytometers and cell sorters, as well as expert operation and advice to its users, so that they can isolate, analyze, and study pure populations of cells from complex tissues, increase our understanding of diabetes and its complications, and ultimately develop treatments and cures for diabetes. Much of the research at Joslin focuses on gaining an understanding of type 1 and type 2 diabetes at the cellular level. This includes studies of the cellular development of pancreatic beta cells, studies of the development and inflammation of metabolically active muscle and adipose cells, and studies of the mediators and modifiers of autoimmunity toward beta cells. All of these research areas require analysis and isolation of well-defined, pure, populations of live cells. Fluorescence activated cell sorting is currently the best method for rapid isolation of very well defined and highly purified, live cells. The Joslin Flow Cytometry Core meets this need. Cell sorting technology is continuously evolving and improving, enabling new approaches to questions in diabetes research. Therefore, a second mission of the Flow Core is to continually update and modernize to offer the most cutting edge cell sorting technology to its users. In addition, because flow cytometry is traditionally thought of as an immunological tool, the Joslin Core's mission includes educational activities that enhance the use of flow cytometry in other research areas, bringing this technology to new users and stimulating new avenues of diabetes research. The specific goals of the Core are: 1. To offer Joslin researchers the use of reliable, well maintained, cutting edge, and cost-efficient cell sorting and analysis machines. 2. To provide training opportunities to Joslin researchers so that they can effectively use flow cytometers and cell sorters, and to continually educate users regarding new applications in flow cytometry that could benefit their research. 3. To update instrumentation in response to new and cutting-edge technology developments, including upgrades to existing instruments, addition of new instrumentation, and establishment of collaborative arrangements to help develop and evaluate new technology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK036836-33
Application #
9701963
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
33
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Rabiee, Atefeh; Krüger, Marcus; Ardenkjær-Larsen, Jacob et al. (2018) Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action. Cell Signal 47:1-15
Cai, Weikang; Xue, Chang; Sakaguchi, Masaji et al. (2018) Insulin regulates astrocyte gliotransmission and modulates behavior. J Clin Invest 128:2914-2926
Nowak, Natalia; Skupien, Jan; Smiles, Adam M et al. (2018) Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int 93:1198-1206
Aguayo-Mazzucato, Cristina; Lee Jr, Terence B; Matzko, Michelle et al. (2018) T3 Induces Both Markers of Maturation and Aging in Pancreatic ?-Cells. Diabetes 67:1322-1331
Bartelt, Alexander; Widenmaier, Scott B; Schlein, Christian et al. (2018) Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity. Nat Med 24:292-303
Fujisaka, Shiho; Avila-Pacheco, Julian; Soto, Marion et al. (2018) Diet, Genetics, and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites. Cell Rep 22:3072-3086
Van Name, Michelle A; Hilliard, Marisa E; Boyle, Claire T et al. (2018) Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr Diabetes 19:114-120
Weisman, Alanna; Lovblom, Leif E; Keenan, Hillary A et al. (2018) Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison. Diabetes Care 41:88-95
Panduro, Marisella; Benoist, Christophe; Mathis, Diane (2018) Treg cells limit IFN-? production to control macrophage accrual and phenotype during skeletal muscle regeneration. Proc Natl Acad Sci U S A 115:E2585-E2593
McGill, Dayna E; Volkening, Lisa K; Pober, David M et al. (2018) Depressive Symptoms at Critical Times in Youth With Type 1 Diabetes: Following Type 1 Diabetes Diagnosis and Insulin Pump Initiation. J Adolesc Health 62:219-225

Showing the most recent 10 out of 1120 publications